# Trial to Optimally Show the Pharmacological Action of Z-100

> **NCT03476018** · PHASE3 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 72 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Z-100
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03476018
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2021-07-20
- **Final completion:** 2021-12-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2022-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03476018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03476018, "Trial to Optimally Show the Pharmacological Action of Z-100". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03476018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*